1. Progressive, multi‐organ, and multi‐layered nature of cancer cachexia
   Yuki Nakamura et al, 2024, Cancer Science CrossRef
2. Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis
   Junfang Zhang et al, 2024, Clinical Nutrition CrossRef
3. Immunotherapy use in older adults with cancer with frailty: A young SIOG review paper
   Deniz Can Guven et al, 2024, Journal of Geriatric Oncology CrossRef
4. CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy
   Hironori Fujii et al, 2024, Journal of Pharmaceutical Health Care and Sciences CrossRef
5. Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
   Junji Furuse et al, 2024, International Journal of Clinical Oncology CrossRef
6. Immune System Disorder and Cancer-Associated Cachexia
   Lingbing Zhang et al, 2024, Cancers CrossRef
7. Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
   Jonas Saal et al, 2023, Clinical & Translational Immunology CrossRef
8. Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
   Yean Yu et al, 2024, Aging CrossRef
9. The role of pharmacists in multimodal cancer cachexia care
   Hironori Fujii et al, 2023, Asia-Pacific Journal of Oncology Nursing CrossRef